Please share what your organisation and Boehringer Ingelheim will Co-Create together
After several conversations with a key stakeholder at BI, it is clear that there is room for significant co-creation.
In particular, we have identified the need for more comprehensive patient and family education tools for Chronic Obstructive Pulmonary Disease (COPD). What if upon diagnosis of COPD, patients were able to have access to critical information pertaining to the disease, how to manage their health and a good understanding of the medication they are prescribed with in a language that they are most comfortable with?
COPD is one of the main drivers of mortality in India, where rates are estimated to be among the highest in the world. Similarly, in Canada, COPD is a leading cause of mortality and morbidity, with prevalence rates of roughly 4%. Unlike other chronic disease states (such as diabetes, heart disease), patient-facing information on COPD is incredibly limited. Noora Health would work with BI to develop comprehensive family caregiver and patient-facing tools to be used among non-English speaking patients in both Canada and India to help families understand and manage their condition.
If you selected "other" above, please explain:
Reaching a new market of COPD patients in rural India (2/3 of 1.25 billion people reside in rural areas). See prevalence below.
Please provide a 1-2 sentence summary of your Co-Creation idea
Together with BI, Noora Health will develop family caregiver and patient-facing education tools that will better equip healthcare providers and patients with the information and tools they need to properly diagnosis and manage COPD. BI has access to best-in-class medical information and tools that, when repackaged by Noora Health for the patient and family caregiver audience can significantly help with the long-term management of this chronic disease.
BI in partnership with Noora Health (and possibly ViperMed) will develop patient education tools that can be accessible to patients at the time of diagnosis in their language of choice. Tools that are relevant to educating patient and their families in rural India will be taken and used by Noora Health to bring awareness to these communities.
The prevalence of COPD reported in studies varied from 2%-22% in males and from 1.2%-19% in females. The prevalence of COPD is not completely understood due to the fact that this disease is often not properly distinguished from asthma and in some cases these patients are diagnosed separately for chronic bronchitis or emphysema.
How does this project link to the core mission of your organisation?
Noora Health's mission is to train family members how to care for their loved ones. With COPD on the rise in India, it is critical that we develop these materials. Working with BI would allow us to fast-track the creation of this content and reach thousands of low-resource patients in desperate need of high quality medical tools.
Beyond social impact, how does this project link to Boehringer Ingelheim’s core business?
BI has a mandate to be more patient-centric - this project would directly feed into this mission by providing patients and their families the opportunity to better manage their condition, reduce the need for unnecessary medical attention, and alleviate the burden on healthcare professionals for non-trivial matters. BI has a wealth of knowledge and resources in the area of respiratory health and, because they manufacture drugs for COPD, have an incentive to ensure that their patients are able to manage and adhere to their drug regime.
What are the specific inputs and actions that each side will contribute to this Co-Creation idea based on each of your unique competencies and experiences?
My organization will contribute:
Deep expertise and knowledge in Human Centered Design: we have been successful in effectively assessing patient needs and developing tools to train patients and their families how to manage their health with indisputable results of reducing return visits to the hospital and empowering people with medical knowledge so they can then apply
this at home without medical experts.
Expertise in developing tools that get behavior change to stick: we have shown sustained behavior change at 30 days around health promoting behaviors, we have shown a 70%+ reduction in preventable post-surgical complications as a result of our training program.
Boehringer Ingelheim will contribute:
Has a wealth of medical knowledge (both internally and via affiliations with external members of the medical community) worldwide
Has the capital means to roll out projects that align directly with BI corporate strategy
Patient- focused initiatives are high on BI's company mandate both in Canada and globally
Please describe the potential revenue model for this Co-Creation idea.
Through the co-creation challenge winning awards, initial funds would be invested in the development of initial patient education tools in the languages identified by those most prevalent of having COPD in Canada and India. The materials will likely be made available online for doctors and pharmacists and/or delivered through in-person trainings (however the delivery mechanism will be set upon further user testing) as well as to those prescribed with a BI drug. Revenue generated from new prescriptions with immediate access to education tools would be evaluated and could possibly become BI’s new product (drug + patient information, revenues from which would be shared w/ Noora Health).
In India, patient education materials could be licensed for a fee to medical practitioners (or materials provided for free in those settings that do not have the resources to pay a licensing fee but can pay for operating costs, following Noora Health's current business model for highly resource-constrained hospital sites).
What possible risks or challenges do you foresee?
Potentially significant differences in the "needs" of patients in Canada and India. It will be interesting to see how much of the information is applicable in these two very different settings. For Noora Health, it has been remarkable to see how similar the family member and patient needs are between India and the US. We anticipate the same being the case for marginalized patients in Canada and India, but we will see. Noora Health uses different teaching methodologies and where there are differences, we can adjust and adapt accordingly as we teach the materials live to the patients and their families in India.
Is there anything else you would like to share about your Co-Creation idea?
If you selected "other" above, please explain:
Besides Boehringer Ingelheim, what other types of partners might be valuable to carrying out your Co-Creation idea, and why?
Partnering with INSPIRE clinics (COPD outreach programs) and Respirologists in order to develop the most effective patient education tool and content.